📌 Key Takeaways
- Topic: Silica and Hydrofluoric Acid Reaction: Equation, Mechanism and Uses
- Keywords: silica matting agent
- Published: 2026-11-20 04:25:21
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Supplier Korea: Key Producers, Demand Sectors and Import Options
- What Is Silane Treated Silica? How Silane Modification Improves Dispersion and Performance
- Even though MSNs can usually be recognized as secure products, their use during therapy may cause side impacts in the body [ 1, 2, 29 ]. Due to their small size and large surface area, they may tend to accumulate in the body, or certain organs (liver, spleen, kidney, lung) and may even be toxic in higher concentrations, which is a clear disadvantage [ 1, 4, 27 ]. The silanol groups (Si-OH) on their surface can interact with the phospholipid layer of the cell membrane, thereby causing cell lysis or, in extreme cases, hemolysis [ 4, 8 ]. In severe cases, the lack of hemocompatibility can also cause issues [ 2 ]. Overall, indications of cytotoxicity, haemotoxicity, and genotoxicity were also found [ 4, 8 ]. That is why the biocompatibility of all comparable preparations must be strictly controlled [ 2, 4, 27 ]. The physicochemical features (particle size, particle morphology, surface chemistry, pore structure, etc.) of nanocarriers also have a major impact on toxicity [ 2, 4, 8, 30 ]. Additionally, further attention must be paid to the biological influences of their decomposition products, because they may also cause unwanted side influences [ 1 ]. The breakdown of silica nanoparticles in the body can take up to a few days. The opening hydration is followed by hydrolysis, and, in the end, they are excreted in the urine in the form of silicic acid [ 1 ]. Nevertheless, the literature is contradictory in this regard [ 31 ]. Some experiments show no considerable cytotoxic effect [ 18, 31 ], while other experiments say otherwise [ 23, 32 ]. For example, an in vitro study was performed with multiple concentrations, surfaces, and particle sizes (60 nm, 100 nm, 300 nm) of MSNs, with an exposure time of 72 h [ 18 ]. This study shown no significant cytotoxic influence in any of the cell lines tested (human cervical (HeLA), epithelial lung (A549), and glioblastoma (U251)) [ 18 ]. Ismail et al. investigated the cytotoxic effect of silica nanoparticles in vivo in mouse models [ 33 ]. Amorphous silica nanoparticles were administered to the animals orally, at a dose of 150 mg/kg/day, for 3 months. Based on these mouse models, no toxic effects were detected under sub-chronic treatment of the nanoparticles [ 31 ]. In another study, particle size (15 nm, 60 nm, 200 nm) dependent impact was observed on cellular viability in all four cell lines tested (THP-1 derived macrophages, A549 epithelial cells, HaCaT keratinocytes, and NRK-52E kidney cells) [ 23 ]. Smaller particles caused notable toxicity on each cell line, after the exposure time of 24 h, in contrast to the larger particles, which demonstrated no cytotoxic impact [ 23 ]. A comparable outcome has been published to verify the toxic characteristic of mesoporous silica. In this in vitro study, the researchers investigated the effect of MSNs with an average size of 7 nm on cell viability at three different concentrations. After 72 h of exposure, only the highest concentration (62.5 µg/mL) caused a substantial decrease in cell viability of human lung fibroblast cells. This toxicity occurred in a time- and dose-dependent manner [ 32 ]. In an in vivo mouse model, MacCuaig et al. presented coating-dependent impacts after repeated intravenous administration of MSNs. Chitosan-coated MSNs induced minor organ changes and were the most biocompatible. Uncoated and especially PEG-coated MSNs (especially 2K PEG) moderately augmented pre-existing vascular or organ lesions, implying that PEGylation has the potential to augment chronic risks, while chitosan enables safer long-term use [ 34 ]. An in vitro study of Barguilla et al. exposed epithelial lung cells to bare, PEG-functionalized, or galacto-oligosaccharide-functionalized MSNs for eight weeks. There was no reported long-term DNA damage, but malignant-like alterations like anchorage-independent growth, boosted migration/invasion, and secretome-facilitated tumor promotion were triggered by PEG- and GAL-functionalized MSNs. Naked MSNs did not cause such alterations and were determined to be safer [ 35 ]. Coating, on the whole, exerts a significant impact on the safety of MSNs. Uncoated MSNs are relatively innocuous; the most biocompatible coatings were achieved with chitosan, but PEG and carbohydrate functionalization can be dangerous in the long run, from vascular toxicity in vivo to tumor-promoting activity in vitro [ 34, 35 ].
- Fused Silica Powder: Purity, Particle Sizes, CTE and Electronic Applications
- 31. Ismail A., Sial N., Rehman R., Abid S., Ismail M.S. Survival, expansion, behavior, hematology and serum biochemistry of mice under different concentrations of orally administered amorphous silica nanoparticle. Toxicol. Rep. 2023;10:659-668. doi: 10.1016/j.toxrep.2023.05.006. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]
- Silica Filler for Plastics: Benefits, Grades and Applications
- 47. Aulifa D.L., Saepudin A.H., Margaretha P., Khairinisa M.A., Budiman A. Characterization of Alpha Mangostin Loaded-Mesoporous Silica Nanoparticle and the Impact on Dissolution and Physical Stability. Nanotechnol. Sci. Appl. 2025;18:1-13. doi: 10.2147/NSA.S499007. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]
- Wollastonite vs Silica: Filler Performance and Applications Compared
- Tamás Sovány
Silica Filler for CCL: How It Improves Copper Clad Laminate Performance
What is silica (SiO₂)?
microsilica for cement The most recent findings and developments of MSN-based therapeutic approaches are displayed in Table 4.
What is the difference between fumed silica and precipitated silica?
silica sand 100. Karaman D.Ṣ., Patrignani G., Rosqvist E., Smått J.-H., Orłowska A., Mustafa R., Preis M., Rosenholm J.M. Mesoporous silica nanoparticles facilitating the dissolution of poorly soluble drugs in orodispersible films. Eur. J. Pharm. Sci. 2018;122:152-159. doi: 10.1016/j.ejps.2018.06.027. [ DOI ] [ PubMed ] [ Google Scholar ]
What drives silica raw material prices?
quartz CAS 14808-60-7 39. Kim D., Koo J., Yang E.-J., Shim K., Tin Y.Y., Lin Z., Oh K.T., Na D.H. Entrapment of celecoxib into mesoporous silica particles for tablets with improved dissolution through amorphization. J. Drug Deliv. Sci. Technol. 2023;84:104485. doi: 10.1016/j.jddst.2023.104485. [ DOI ] [ Google Scholar ]
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.